chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initially had a typical injection site reaction the day of the shot (about 4 hours later). This included a round circle of redness and swelling around the injection site, along with pain and warmth. This subsided, fading to a bruise and pain went away. On the morning of Day 7 after vaccination my injection site became very itchy and progressively red throughout the day. On the morning of Day 8 I woke up to my injection site being very swollen and bright red. My entire arm is swollen, up into my face. My arm is extremely hot. The itching is better but painful now.
Received inactivated flu vaccine approx. 0830 11/15/06 was sent to outpatient tx. unit approx 1440 with c/o itching then dry cough and some dypsnea. BP 122/79, P 91, R 22 O2 sat 100%, 1444 epinephrine 0.4 given IM right deltiod, albuteral via nebulizer x3 starting at 1445, IV of 0.9%NS started , 1505 Benadryl 50mgm given IVP, 1510 Solu-medrol 125mggm given IVP at this time BP 146/71, P123, O2 sat 98%. Monitored for 3 hours and discharged to home-respiratory symptoms resolved
This case was reported by a consumer via call center representative and described the occurrence of injection site bleeding in a 57-year-old female patient who received BOOSTRIX. Concurrent medical conditions included blood cholesterol abnormal. Concomitant products included ZOSTAVAX and medication unknown, medication unknown (Cholesterol medication (NOS)). On 27th November 2016, the patient received BOOSTRIX. On an unknown date, immediately after receiving BOOSTRIX, the patient experienced injection site bleeding and injection site bruising. On an unknown date, the outcome of the injection site bleeding was recovered/resolved and the outcome of the injection site bruising was not recovered/not resolved. It was unknown if the reporter considered the injection site bleeding and injection site bruising to be related to BOOSTRIX. Additional details were provided as follows: The reporter is spouse of the patient. The patient received BOOSTRIX along with ZOSTAVAX vaccine on the same arm. However, reporter stated that the ZOSTAVAX vaccine was given at a different spot on the same arm. It was reported that, the patient bled at the injection site upon injection. The patient also experienced bruise at the injection site where she received the BOOSTRIX vaccine and she was still having bruise at the time of reporting. The reporter was concerned that the patient might not get all the vaccine that she was supposed to get.
This is a spontaneous report received from a contactable consumer or other non-HCP, for a Pfizer sponsored program (003110). A 1-year-old female patient exposed to the 1st and 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), via transmammary; both single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient had exposure via breast milk (breast-feeding), with outcome of unknown; and illness (sick), with outcome of recovered. Additional information: The patient got sick but got better into two days. The reporter believed she developed some natural immunity through breastfeeding. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected. Sender's comments: Linked report: US-PFIZER INC-202200132872 (patient's mother's case).
Pt recvd 1st dose of Engerix-B 22NOV89,2nd vax 08JAN90,& 3rd on 23MAY90. Titer indicated pt. was non-responder.Booster vax was from same lot given & another titer indicated nonresponder.
Swollen Arm, Muscle Aches, 100 F Temperature, restless sleep.
low platelet count; swollen lymph nodes in neck; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old male patient received bnt162b2 (BNT162B2), administration date 10Jun2021 13:30 (Lot number: EW0186) at the age of 54 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ew0186, Vaccine Administration Time: 01:30 PM), administration date: 20May2021, when the patient was 54 years old, for Covid-19 Immunization. The following information was reported: PLATELET COUNT DECREASED (non-serious) with onset 15Oct2021, outcome "unknown", described as "low platelet count"; LYMPHADENOPATHY (non-serious) with onset 15Oct2021, outcome "unknown", described as "swollen lymph nodes in neck". The events "low platelet count" and "swollen lymph nodes in neck" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of platelet count decreased, lymphadenopathy. Additional Information: The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient not received list of any other medications within 2 weeks of vaccination. patient not diagnosed with COVID-19 prior to vaccination .  No follow-up attempts are possible. No further information is expected.
shot was more painful took it twice and still feeling it; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of pain (1st dose received on an unknown and experienced more painful, refer case US2021AMR160938).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received the 2nd Shingles shot and that was more painful and still feeling it and never event wanted to take again. The follow up would not be possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR160938:same patient, same reporter, same suspect, differnet dose (1st)
Cutaneous eruption, pruritic in nature, consisting of edematous papules and papulovesicles on acral surfaces, extensor extremities starting 1/13/21 reportedly after 1/6/21 vaccination per above. Symptoms and presentation improved with oral benadryl, oral prednisone taper initiation (planned for 3 weeks in total), and topical corticosteroids. No mucosal involvement, no systemic symptoms.
neuropathy was really bad/felt worse when sitting and laying; couldn't sleep; felt sick to her stomach; felt really bad; injection arm sore; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (neuropathy was really bad/felt worse when sitting and laying) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (Medical history not provided).   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection arm sore). On 30-Mar-2021, the patient experienced NEUROPATHY PERIPHERAL (neuropathy was really bad/felt worse when sitting and laying) (seriousness criterion medically significant), INSOMNIA (couldn't sleep), ABDOMINAL DISCOMFORT (felt sick to her stomach) and FEELING ABNORMAL (felt really bad). On 31-Mar-2021, VACCINATION SITE PAIN (injection arm sore) had resolved. At the time of the report, NEUROPATHY PERIPHERAL (neuropathy was really bad/felt worse when sitting and laying), INSOMNIA (couldn't sleep), ABDOMINAL DISCOMFORT (felt sick to her stomach) and FEELING ABNORMAL (felt really bad) outcome was unknown.            Concomitant medication use was not provided.  Treatment information was not reported.  This case concerns a 73-year-old female with a serious unexpected event of neuropathy peripheral, and nonserious unexpected feeling abnormal, abdominal discomfort, insomnia, and expected vaccination site pain. Event onset the same day as second dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 73-year-old female with a serious unexpected event of neuropathy peripheral, and nonserious unexpected feeling abnormal, abdominal discomfort, insomnia, and expected vaccination site pain. Event onset the same day as second dose mRNA-1273. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
temperature excursion; This spontaneous report has been received from a medical assistant referring to a patient of unknown age. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.     On an unknown date, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 ml, lot # S022599 with expiration date of 25-FEB-2022 (strength, dose, route, frequency, and anatomical location were not provided) for prophylaxis. The vaccine was exposed to a temperature of 1.8 °C during a time frame of 7 hours and 25 minutes.
Ringing ears immediately after the first, second shots for a day, then plugged ears, muffled sound for 2 weeks. It was like having water in my ears. Contracted Covid 12/2021. Post diagnosis I had plugged ears, muffled sound for 2 weeks. It was like having water in my ears. Got the booster. I had ringing ears immediately after shot for several hours, then plugged ears, muffled sound for 4 weeks. Went to the Dr. and was prescribed steroids and antibiotics. After two weeks, my symptoms have subsided.
11/7/18 after SHINGRIX #2 she had sore arm and "just didn't feel good" for 1-2 days after which she attributed to the vaccine but was not concerned about. (Patient reported she did not have arm pain or similar feeling of not feeling well after her SHINGRIX #1 vaccination which was given 5/16/18.)  On 11/10/18 patient had apparent (by history & clinical findings) new onset seizure. She was evaluated at  Emergency Room and admitted for evaluation observation 11/10/18-11/11/18. She appeared to have recovered completely without any ongoing symptoms at the time of discharge. Was seen in clinic for follow-up by myself 11/12/18. Patient is aware not able to tell if her seizure is related to the SHINGRIX vaccination for certain but that was the only change she was able to identify prior to the apparent seizure episode.
20 Patients received Spikevax past the 30 day expiration date; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023C22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (20 Patients received Spikevax past the 30 day expiration date).    This case was created for 18th patient of 20 patients Concomitant medication was not provided. Treatment medication was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-700683.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-700683:Master case
diarrhea; This is a spontaneous report from a contactable consumer (patient, self-reported). This 64-Year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number and expiry date was unknown) via an unspecified route of administration on 23Mar2021(age at the time 64-year-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient was not able to get the 2nd dose on time since he felt ill, mentioned he had "diarrhea" after the first dose. The patient had a word with nursing department. The patient wanted to know if he can still get the second dose given the timing. The outcome of the event was unknown.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
After second vaccine, I had extreme burning sensations under my skin all over my body without rash.  Flushing speckled skin. Extreme congestion, with fluid back up in right ear.  Extreme difficulties sleeping.  Beyond extreme fatigue and brain fog.
had both of Shingle vaccine. I just now was diagnosed with Shingles / Suspected Vaccination failure; diagnosed with Shingles / It is very uncomfortable; uncomfortable; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and discomfort. On an unknown date, the outcome of the vaccination failure, shingles and discomfort were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and discomfort to be related to Shingles vaccine and Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had both of Shingle vaccine and just now was diagnosed with Shingles and informed that his or her case should be mild. It was very uncomfortable. The reporter hate to see what it would be like without the vaccinations and informed to get the shots. This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
This is a spontaneous report from a non-contactable consumer reporting for the daughter. This female patient of an unspecified age, race and ethnicity received a single dose of TRUMENBA via an unspecified route of administration on 02Mar2017 for immunization.  The patient medical history and concomitant medications were not reported.  Since the day of vaccination the patient experienced body ache (whole body hurt) and low grade fever (body temperature was at 100 F), injection site really hurt a lot, she had flu like symptoms and chills. Outcome of events was unknown. No follow-up attempts are possible. No further information is expected.
Pt recvd Engerix-B on 26APR90, 29MAY90, 23OCT90 subsequently was found neg Anti-HBS p/3 doses @ 1mo, 2mo, & 6mo intervals;
Patient was very nervous at the time of vaccine.  After the vaccine was administered, the patient went to sit for 15 minutes afterwards and her whole body was shaking.  We assessed the patient, provided her water and orange juice and monitored her.  She declined for us to call the hospital and stated that she was nervous about getting the vaccine.  She initially felt flushed but as we sat and talked to her, the shaking subsided and the patient felt fine to leave.  She declined getting her blood pressure or blood sugar checked.  We had her stand up slowly and assessed her gait to make sure she was feeling okay, and she appeared to be standing normally.  She stated that she felt fine to leave.  She said that she was not driving and that her husband was going to come and pick her up.
Staff had her 2nd vaccine on Thursday 01/28/2021.  From Friday 01/29/2021 started nausea.  Because of nausea, staff feels dizzy, scratchy throat and cough.  Staff still feeling nausea.
pt had hives all over body for 1wk;MD said give pt DPH;
Arm pain, nauseous, headache, slight fever 99.8, and chills
Wednesday had headches, chills, nausea, fatigue and tired. Thursday still feeling the same. Friday started with red rash with itching front of neck both sides. Sat and Sunday same thing. Today, still red and itching a little.
She was admitted due to acute on chronic hypoxemic and hypercapnic respiratory failure.  She was using noninvasive ventilation at night and as needed during the day when she was admitted.  She also had issues with recurrent left-sided pleural effusion that required recurrent thoracentesis.     Her hospitalization was characterized by recurrent and progressive hypercapnia in association with weakness that was generalized despite working with occupational and physical therapy.  She had a small bore chest tube placed by Interventional Radiology for her pleural effusion.  This did not provide significant improvement in her overall cardiopulmonary status.  She continued to have progressive hypercapnia despite noninvasive ventilation characterized by delirium.  Her family eventually decided to transition her from active care to comfort care with palliation.  She died on July 13, 2023 at 1955.
Pt reports symptoms similar to facial palsy starting approx 1 day after administration and still occurring during first report to clinic on 9/9/21. Clinic had attempted to contact patient about completing series and patient reported palsy symptoms occurring soon after admin of first dose.  Pt asked if she should see a neurologist and clinic agreed that seeing a neurologist as soon as possible would be in the best interest of the patient.
pt recvd APAP & went to seleep; woke up slightly & started to vomit; pt was real pale & unresponsive; called ER;
Came in 7/26/18 reported injection site reaction on left arm warmth redness and painful pustule that started 5 days prior (7/21/18). No reported initial reaction but said started feeling warm a week later.
Pt here today stating that on 10/2/18 she received her flu vaccine (Flulaval 0.5mL dose; Lot 2B55B; Manufacturer ID Biomedical) in left deltoid. Pt states she had no problems or concerning issues for a month after vaccination. On 11/2 Pt was going out of town visiting daughter and rode in the car for 4 hours to get there. When she got out of the car she started feeling dizzy. She was able to walk to the entrance of the mall but the dizziness lasted a couple of minutes. Pt was hydrated well. She has no history of blood pressure problems or sugar problems. Pt had 3 more episodes that same night on 11/2. Each one progressively got worse. The 2nd episode Pt had to hold onto the wall to keep from falling down from dizziness. The 3rd episode she had to sit down in a dressing room to keep from falling in the floor. The 4th one she was driving to daughter's apartment and pulled over and had a hard time walking around the car to the passenger seat without falling due to dizziness. This last episode was the longest lasting from 10-15 minutes. Pt had had breakfast, lunch, and dinner that day. After that 10-15 minutes Pt was able to walk a large distance into apartment building and went to sleep without problems. The next time Pt had an episode was on 11/6. Pt was in the middle of teaching and started feeling as if she was going to get dizzy again. She continued to teach her class and had another episode as well where she felt like she was going to get dizzy but did not. These lasted about a couple minutes each. Pt has had no episodes since. During all of these episodes Pt had no nausea, vomiting, headache, diarrhea, or recent viral illness. She describes these episodes as "the world was spinning." She also became very hot during episodes.
6 weeks  old found unresponsive by foster parents at 1230 PM. Cyanotic and CPR initiated- brought to ED via ambulance, patient transferred. Now deceased. Coroner's office.
Tested positive for low von willebrande factor; After 2 dose I started to bruise extremely easily; the migraine like symptoms increased to multiple times per week with extreme sen; extreme sensitivity to light and vomiting; extreme sensitivity to light and vomiting; Cuts that would bleed excessively; Nose bleeds; A 27-year-old (Non-pregnant) female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number:ER8727) via unspecified route of administration in left arm on 31Mar2021 13:00 as (at age of 27years) 2nd dose, single dose for COVID-19 Immunization. Patient medical history includes Attention deficit hyperactivity disorder (ADHD), Anxiety from unspecified date and unknown till ongoing. Patient is allergic to the drugs include Penicillin, Omeprazole from unknown date till ongoing. Patient concomitant medications include lisdexamfetamine mesilate(VYVANSE) and drospirenone, ethinylestradiol(GIANVI) used for unspecified indication from unknown date and unknown if ongoing. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6207) via unspecified route of administration in left arm on 11Mar2021 09:00 (at age of 27years) as single dose for COVID-19 Immunization and experienced 1 week after first dose patient began getting severe migraine like symptoms followed by extremely heavy menstrual cycle. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID. On unspecified date, after 2 dose patient started to bruise extremely easily and the migraine like symptoms increased to multiple times per week with extreme sensitivity to light and vomiting. Patient had cuts that would bleed excessively, woke up with nose bleeds and tested positive for Low von willebrande factor with no history of any type of bleeding disorder. The adverse events resulted in physician office visit. Patient received treatment for events .Patient underwent lab test and procedures include CT Scan of head, blood tests result was unknown and vonwillebrande was positive . The Clinical outcome of all events was Recovering.   Information on the lot/batch number has been requested.